Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Evotec SE

Market Cap 848M 981M 781M 731M 1.37B 93.27B 1.39B 9.22B 3.6B 45.4B 3.68B 3.6B 157B P/E Ratio 2026 *
-6.71x
P/E Ratio 2027 * -24.4x
Enterprise Value 862M 998M 794M 743M 1.39B 94.84B 1.41B 9.38B 3.66B 46.16B 3.74B 3.67B 160B EV / Sales 2026 *
1.17x
EV / Sales 2027 * 1.12x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-4.57%
Current month-10.68%
1 month-4.38%
3 months+9.95%
6 months-9.73%
Current year-14.36%
1 week 4.58
Extreme 4.582
4.9
1 month 4.53
Extreme 4.526
5.33
Current year 4.02
Extreme 4.017
6.66
1 year 4.02
Extreme 4.017
7.8
3 years 4.02
Extreme 4.017
24.45
5 years 4.02
Extreme 4.017
45.7
10 years 3.3
Extreme 3.3
45.7
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO - 2026-04-30
Chief Operating Officer - 2026-04-30
Director TitleAgeSince
Director/Board Member 58 2019-06-18
Director/Board Member 64 2021-05-31
Director/Board Member 43 2022-06-21
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-4.57% - - 981M
-0.35%+0.97%-15.96%-12.73% 43.03B
+3.11%+3.11%+274.29%+507.94% 32.71B
+0.22%-1.08%+14.03%-14.37% 30.29B
+1.62%-2.08%-4.36%+24.05% 29.4B
+4.09%+0.93%+10.83%+18.78% 25.08B
-1.63%+2.88%+53.73%+114.36% 13.35B
+1.14%+3.62% - - 13.54B
-0.40%-1.29%+6.06%+7.59% 12.97B
-0.74%-1.62%+105.71%+76.01% 12.11B
Average +0.72%+1.45%+55.54%+90.21% 23.61B
Weighted average by Cap. +1.05%+1.48%+54.94%+97.30%

Financials

2026 *2027 *
Net sales 738M 854M 680M 636M 1.19B 81.17B 1.21B 8.03B 3.13B 39.51B 3.21B 3.14B 137B 818M 947M 754M 705M 1.32B 90B 1.34B 8.9B 3.47B 43.81B 3.55B 3.48B 152B
Net income -113M -131M -104M -97.67M -183M -12.46B -186M -1.23B -480M -6.07B -492M -482M -21B -30.42M -35.22M -28.03M -26.24M -49.18M -3.35B -49.94M -331M -129M -1.63B -132M -129M -5.64B
Net Debt 14.3M 16.56M 13.18M 12.33M 23.12M 1.57B 23.47M 156M 60.67M 766M 62.14M 60.81M 2.65B 69.32M 80.27M 63.88M 59.8M 112M 7.63B 114M 754M 294M 3.71B 301M 295M 12.86B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,526
Date Price Change Volume
26-06-12 4.676 +0.17% 600
26-06-11 4.668 -0.60% 2,000
26-06-10 4.696 -0.76% 4,050
26-06-09 4.732 -3.43% 7,670
26-06-08 4.900 0.00% 1,890
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
4.768EUR
Average target price
6.443EUR
Spread / Average Target
+35.13%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!